Evaluation of the Regenerative Medicine & Nanomedicine Initiative / : Évaluation de l'Initiative de recherche en médecine régénératrice et nanomédecine

In keeping with CIHR’s requirements to evaluate under the Treasury Board of Canada Secretariat’s 2009 Policy on Evaluation, issues related to relevance are also addressed including the continued need for RMNI and the sustainability of funding for researchers in the fields of regenerative medicine and nanomedicine. [...] When considering the relevance and continued need for the initiative as well as the sustainability of funding for researchers in regenerative medicine and nanomedicine: The objectives of RMNI are in alignment with the Government of Canada's Science and Technology Strategy and CIHR’s 2009-2014 strategic plan and recent federal budgets continue to affirm the government’s commitment and role of CIH [...] As recommended in the Translation relative to the Canada in the fields evaluation, an approach to this will be Portfolio Open of regenerative to undertake a review of the extent to Operating medicine and which those who were funded under Grants nanomedicine in the this initiative are now receiving grants Program and absence of RMNI. [...] One of the primary objectives of CIHR’s Regenerative Medicine and Nanomedicine Initiative (RMNI) is to fund research projects with the potential for generating high impact results to ensure Canada’s strong and growing presence in the fields of regenerative medicine and nanomedicine. [...] Global and National Publication Rates in Regenerative Medicine and Nanomedicine To contextualize the performance of RMNI in terms of knowledge creation and scientific impact, it is useful to first briefly consider global and national publication rates for the fields of regenerative medicine and nanomedicine.